ClinicalTrials.gg
RecruitingNCT07313839BI-SUREUpdated Jun 17, 2026

Comparison of Self-Locking Versus Traditional Sutures in Double-Layer Laparoscopic Vaginal Vault Closure After Hysterectomy (BI-SURE Trial)

An interventional study of Double-Layer Vaginal Vault Closure with Self-Locking Suture and Double-Layer Vaginal Vault Closure with Polyglactin 910 in Gynecologic Cancers, Vaginal Cuff Dehiscence and Postoperative Complications, sponsored by Azienda Ospedaliero-Universitaria di Parma. Recruiting at 5 sites in Italy. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-17.

Sponsored by Azienda Ospedaliero-Universitaria di Parma · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
310
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 59 studies in Postoperative Complications with a site in Italy — 16 open to participants now, 18 under way, 1 of them phase 3. Postoperative Complications · Italy.

Planned enrollment
6th of 35
310 · median 150
Started
2025
with 3 others
No phase
30 of 59
6 open now
Primary completion
2027-01
later than 8 of 17 live
Registered
51st of 59
by date
Lead sponsor
3 of 59
Azienda Ospedaliero-Universitaria di Parma

Among the 59 studies in Postoperative Complications with a site in Italy, this one is the 6th largest by planned enrollment of the 35 interventional ones that give a count, is one of 4 that started in 2025, is one of 30 with no phase, reaches primary completion later than 8 of the 17 other live ones, and was the 51st registered.

Postoperative Complications

1,343 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.

Browse Postoperative Complications studies →

Open to participants now

16 of the 59 studies in Postoperative Complications with a site in Italy are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 200 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 31 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 59 studies in Postoperative Complications with a site in Italy, or all of them as a file.
02

Study summary

Vaginal vault closure after laparoscopic or robotic hysterectomy may be associated with postoperative complications such as vaginal cuff dehiscence, infection, and bleeding. The optimal suture material and technique for laparoscopic colporrhaphy, particularly in patients undergoing surgery for gynecologic malignancies, remain controversial.

The BI-SURE trial is a multicenter, randomized controlled study designed to compare double-layer self-locking sutures versus double-layer traditional Polyglactin 910 sutures for laparoscopic vaginal vault closure after hysterectomy. The study aims to evaluate postoperative effectiveness and safety within three months after surgery.

Read the detailed description

Laparoscopic and robotic hysterectomy represent standard surgical approaches for the treatment of gynecologic malignancies but are associated with a higher risk of vaginal vault complications compared with open or vaginal surgery. Although uncommon, postoperative complications such as vaginal cuff dehiscence, infection, and bleeding may lead to significant morbidity and require additional medical or surgical interventions.

Vaginal vault closure can be performed using different suturing techniques and materials. Traditional braided sutures, such as Polyglactin 910, are widely used in clinical practice, while self-locking (barbed) sutures have been introduced to facilitate laparoscopic suturing by maintaining tissue approximation without the need for knots. Evidence comparing these sutures is limited, particularly for double-layer closure techniques and in patients treated for gynecologic malignancies.

The BI-SURE trial is a multicenter, pragmatic, randomized controlled trial designed to compare double-layer self-locking sutures versus double-layer traditional Polyglactin 910 sutures for laparoscopic vaginal vault closure following hysterectomy for malignant gynecologic disease. Eligible patients will be randomized in a 1:1 ratio. Postoperative outcomes will be assessed up to three months after surgery, including vaginal cuff-related complications and postoperative pain.

03

Conditions studied

  • Gynecologic Cancers
  • Vaginal Cuff Dehiscence
  • Postoperative Complications

Keywords

  • Laparoscopic hysterectomy
  • Vaginal vault closure
  • Colporrhaphy
  • Self-locking suture
  • Barbed suture
  • Polyglactin 910
  • Gynecologic oncology
  • Postoperative complications
  • Randomized controlled trial
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing laparoscopic or robotically assisted hysterectomy for gynecologic malignant disease
  • Age ≥ 18 years
  • Ability to provide written

Exclusion criteria

Exclusion Criteria:

  • Laparotomic or vaginal hysterectomy
  • to laparoscopic vaginal vault closure
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
310 participants (estimated)

Study arms

  • Experimental
    Self-Locking Suture Group

    Participants randomized to this arm will undergo laparoscopic vaginal vault closure after hysterectomy using a double-layer continuous suturing technique performed with a self-locking (barbed) suture, according to current clinical practice.

    Procedure: Double-Layer Vaginal Vault Closure with Self-Locking Suture

  • Active comparator
    Traditional Suture Group

    Participants randomized to this arm will undergo laparoscopic vaginal vault closure after hysterectomy using a double-layer continuous suturing technique performed with traditional braided Polyglactin 910 suture, according to current clinical practice.

    Procedure: Double-Layer Vaginal Vault Closure with Polyglactin 910

Interventions

  • ProcedureDouble-Layer Vaginal Vault Closure with Self-Locking Suture

    Laparoscopic vaginal vault closure performed using a double-layer continuous suturing technique with a self-locking (barbed) suture following hysterectomy.

  • ProcedureDouble-Layer Vaginal Vault Closure with Polyglactin 910

    Laparoscopic vaginal vault closure performed using a double-layer continuous suturing technique with traditional braided Polyglactin 910 suture following hysterectomy.

06

What researchers measure

Primary outcomes

  1. Vaginal cuff dehiscence rate

    Proportion of participants experiencing vaginal cuff dehiscence requiring surgical reintervention after laparoscopic hysterectomy.

    Time frame: Within 3 months after surgery

  2. Vaginal cuff infection rate

    Proportion of participants developing vaginal cuff infection, defined as abnormal vaginal discharge with or without fever, leukocytosis, and/or local tenderness, requiring antibiotic therapy.

    Time frame: Within 3 months after surgery

  3. Postoperative bleeding rate

    Proportion of participants experiencing postoperative vaginal cuff bleeding requiring hemostatic treatment.

    Time frame: Within 3 months after surgery

Secondary outcomes

  1. Postoperative pain intensity

    Postoperative pain assessed using the Visual Analogue Scale (VAS).

    Time frame: At 1 month and 3 months after surgery

  2. Early postoperative composite complication rate

    Proportion of participants experiencing vaginal cuff dehiscence, infection, or bleeding before the initiation of adjuvant therapy.

    Time frame: Within 1 month after surgery

07

Study locations

2 of 5 sites recruiting
  • Department of Medicine and Surgery, University Hospital of Parma
    Parma, Italy 43125, Italy
    Recruiting
  • Division of Oncologic Gynecology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
    Bologna, Italy
    Not yet recruiting
  • Department of Obstetrics and Gynecology, Ospedale Santa Croce e Carle, Cuneo, Italy.
    Cuneo, Italy
    Recruiting
  • Department of Gynecologic Oncology. Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
    Milan, Italy
    Not yet recruiting
  • Clinic of Obstetrics and Gynecology, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
    Udine, Italy
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared because the study is conducted within a hospital-based academic setting and no data repository has been designated for public data release. Data will be stored securely at the sponsor institution and will be accessible only to authorized study personnel in compliance with applicable privacy regulations.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Jan 2027, 15 months after the start.

Of 395 non-industry interventional studies with no phase under Postoperative Complications, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 44. This study's planned 15 months is below that.

Counting every sponsor, half of 399 studies reached it within 20 months; a quarter within 8 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 18, 2025
First posted
Jan 2, 2026
StartActual
Oct 7, 2025
Primary completionEst.
Jan 2027
CompletionEst.
Jan 2027
Last update
Jun 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07313839
Lead sponsor
Azienda Ospedaliero-Universitaria di Parma
Responsible party
Vito Andrea Capozzi (Principal Investigator, Azienda Ospedaliero-Universitaria di Parma) — Principal investigator
First posted
Jan 2, 2026
Start date
Oct 7, 2025
Primary completion
Jan 2027 (estimated)
Completion
Jan 2027 (estimated)
Last update
Jun 17, 2026

Study contacts

Vito Andrea Capozzi
Contact
vcapozzi@ao.pr.it
0521704819

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion